Cyclin D1 Antikörper (Internal Region)
Kurzübersicht für Cyclin D1 Antikörper (Internal Region) (ABIN2613417)
Target
Alle Cyclin D1 (CCND1) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Güteklasse
-
-
Bindungsspezifität
- Internal Region
-
Verwendungszweck
- cyclin D1
-
Sequenz
- TRFLSRVIKC DPD
-
Kreuzreaktivität
- Human
-
Aufreinigung
- Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
Western Blot: Approx 30 kDa band observed in Human Placenta lysates (calculated MW of 33.7 kDa according to NP_444284.1). Recommended concentration: 0.5-1.5 μg/mL.
Peptide ELISA: antibody detection limit dilution 1:8000.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.5 mg/mL
-
Buffer
- Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Minimize freezing and thawing.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.
-
-
- Cyclin D1 (CCND1)
-
Andere Bezeichnung
- CCND1
-
Hintergrund
- CCND1, cyclin D1, BCL1, D11S287E, PRAD1, U21B31, B-cell CLL/lymphoma 1, B-cell lymphoma 1 protein, BCL-1 oncogene, G1/S-specific cyclin-D1, PRAD1 oncogene
-
Gen-ID
- 595
-
NCBI Accession
- NP_444284
-
Pathways
- PI3K-Akt Signalweg, Zellzyklus, Mitotic G1-G1/S Phases, ER-Nucleus Signaling
Target
-